Incremental Expression of 14-3-3 Protein Beta/Alpha in Urine Correlates with Advanced Stage and Poor Survival in Patients with Clear Cell Renal Cell Carcinoma |
Kaneko, Shiho
(Department of Urology, Kitasato University School of Science)
Matsumoto, Kazumasa (Department of Urology, Kitasato University School of Science) Minamida, Satoru (Department of Urology, Kitasato University School of Science) Hirayama, Takahiro (Department of Urology, Kitasato University School of Science) Fujita, Tetsuo (Department of Urology, Kitasato University School of Science) Kodera, Yoshio (Department of Physics, Kitasato University School of Science) Iwamura, Masatsugu (Department of Urology, Kitasato University School of Science) |
1 | Aitken A (1996). 14-3-3 and its possible role in co-ordinating multiple signaling pathways. Trends Cell Biol, 6, 341-7. DOI |
2 | Amato RJ (2005). Renal cell carcinoma: review of novel single agent therapeutics and combination regimens. Ann Oncol, 16, 7-15. DOI |
3 | Bissler JJ, Kingswood JC (2004). Renal angiomyolipomata. Kidney Int, 66, 924-34. DOI |
4 | Frank I, Blute ML, Cheville JC, et al (2003). Solid renal tumors: an analysis of pathological features related to tumor size. J Urol, 170, 2217-20. DOI |
5 | Fu H, Subramanian RR, Masters SC (2000). 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol, 40, 617-47. DOI |
6 | Greene FL, Page DL, Fleming ID, et al (2002). AJCC Cancer Staging Manual, 6th edn. Springer, New York. |
7 | Jinzaki M, Tanimoto A, Narimatsu Y, et al (1997). Angiomyolipoma: imaging findings in lesions with minimal fat. Radiol, 205, 497-502. DOI |
8 | Liou JY, Wu CC, Chen BR, et al (2008). Nonsteroidal anti-inflammatory drugs induced endothelial apoptosis by perturbing peroxisome proliferator-activated receptor-delta transcriptional pathway. Mol Pharmacol, 74, 1399-1406. DOI |
9 | Lipworth L, Tarone RE, McLaughlin JK (2006). The epidemiology of renal cell carcinoma. J Urol, 176, 2353-8. DOI |
10 |
Liu TA, Jan YJ, Ko BS, et al (2011). Increased expression of 14-3-3 |
11 | Lowrance WT, Ordonez J, Udaltsova N, et al (2014). CKD and the risk of incident cancer. J Am Soc Nephrol, 25, 2327-34 DOI |
12 | Masakazu W, Mitsuru M, Kazuya M, et al (2014). Risk Factors for Renal Cell Carcinoma in a Japanese Population. Asian Pac J Cancer Prev, 15, 9065-70. DOI |
13 | Matsuura K, Nakada C, Mashio M, et al (2011). Downregulation of SAV1 plays a role in pathogenesis of high-grade clear cell renal cell carcinoma. BMC Cancer, 11, 523-32. DOI |
14 | Mhawech P (2005). 14-3-3 proteins-an update. Cell Res, 15, 228-236. DOI |
15 | Ngo TC, Wood CG, Karam JA (2014). Biomarkers of renal cell carcinoma. Urol Oncol, 32, 243-51. DOI |
16 | Morrison DK (2009). The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol, 19, 16-23. DOI |
17 | Mues AC, Palacios JM, Haramis G, et al (2010). Contemporary experience in the management of angiomyolipoma. J Endourol, 24, 1883-6. DOI |
18 | Musholt TJ, Brehm C, Hanack J, et al (2006). Identification of differentially expressed genes in papillary thyroid carcinomas with and without rearrangements of the tyrosine kinase receptors RET and/or NTRK1. J Surg Res, 131, 15-25. DOI |
19 | Nguyen MM, Gill IS, Ellison LM (2006). The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results Program. J Urol, 176, 2397-400. DOI |
20 | Patil S, Ishill N, Deluca J, et al (2010). Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients. Cancer, 116, 347-54. DOI |
21 | Qi W, Liu X, Qiao D, et al (2005). Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer, 113, 359-63. DOI |
22 | Satoru M, Masatsugu I, Yoshio K, et al (2011). 14-3-3 Protein beta/alpha as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid. Anal Bioanal Chem, 401, 245-52. DOI |
23 | Siegel R, Naishadham D, Jemal A (2012). Cancer statistics. CA Cancer J Clin, 62, 10-29. DOI |
24 | Sugiyama A, Miyagi Y, Komiya Y, et al (2003). Forced expression of antisense14-3-3beta RNA suppresses tumor cell growth in vitro and in vivo. Carcinogenesis, 24, 1549-59. DOI |
25 | Weiss RH, Lin PY (2006). Kidney cancer: identification of novel targets for therapy. Kidney Int, 69, 224-32. DOI |
26 | Takihara Y, Matsuda Y, Hara J (2000). Role of the beta isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation. Carcinogenesis, 21, 2073-7. DOI |
27 | Washio M, Mori M, Mikami K, et al (2013). Cigarette smoking and other risk factors for kidney cancer death in a Japanese population: Japan collaborative cohort Study for Evaluation of Cancer Risk (JACC study). Asian Pac J Cancer Prev, 14, 6523-8. DOI |
28 | Wei C, Lai YQ, Li XX,Ye JX (2013). TGF-beta-activated kinase-1: a potential prognostic marker for clear cell renal cell carcinoma. Asian Pac J Cancer Prev, 14, 315-20. DOI |
29 | Wen RM, Zhang YJ, Ma S, et al (2015). Preoperative neutrophil to lymphocyte ratio as a prognostic factor in patients with non-metastatic renal cell carcinoma. Asian Pac J Cancer Prev, 16, 3703-8. DOI |
30 | Wu Q, Liu CZ, Tao LY, et al (2012). The clinicopathological and prognostic impact of 14-3-3 protein isoforms expression in human cholangiocarcinoma by immunohistochemistry. Asian Pac J Cancer Prev, 13, 1253-9. DOI |
31 | Yang X, Cao W, Lin H, et al (2009). Isoform-specific expression of 14-3-3 proteins in human astrocytoma. J Neurol Sci, 276, 54-9. DOI |
32 | Yu ZH, Zhang Q, Wang YD, et al (2013). Overexpression of cyclooxygenase-1 correlates with poor prognosis in renal cell carcinoma. Asian Pac J Cancer Prev, 14, 3729-4. DOI |
33 | Zhao J, Meyerkord CL, Du Y, et al (2011). 14-3-3 proteins as potential therapeutic targets. Semin Cell Dev Biol, 22, 705-12. DOI |
![]() |